Pancuronium Bromide as the Sole Muscle Relaxant for Major Surgery
Robert W. Vaughan, MIRANDA COBB
Abstract
Robert W. Vaughan, MIRANDA COBB
Abstract
Intravenous pancuronium bromide in an initial dose of 0.1 mg./kg. and increments of 0.02 mg./ kg. was found effective and predictable as the sole muscle relaxant in 125 adults undergoing major abdominal or thoracic surgical procedures under nitrous oxide (N20)-oxygen (O2) -fentanyl anesthesia. Dose-response relationships, as judged by duration of relaxation using a peripheral nerve stimutor, were unaffected by age. Intubation was found satisfactory in all age groups at either 3 or 5 minutes after pancuronium administration. Reversal of neuromuscular blockade was complete and predictable in all patients; however, the shortest duration of anesthesia in this study was 55 minutes. It is concluded that pancuronium bromide (0.1 mg./kg.) should provide a valuable alternative to d-tubocurarine for intubation and subsequent relaxation in adults from 18 to 86 years of age. Findings were consonant with the hypothesis that a depolarizing muscle relaxant need not be used with pancuroninum.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Intravenous pancuronium bromide in an initial dose of 0.1 mg./kg. and increments of 0.02 mg./ kg. was found effective and predictable as the sole muscle relaxant in 125 adults undergoing major abdominal or thoracic surgical procedures under nitrous oxide (N20)-oxygen (O2) -fentanyl anesthesia. Dose-response relationships, as judged by duration of relaxation using a peripheral nerve stimutor, were unaffected by age. Intubation was found satisfactory in all age groups at either 3 or 5 minutes after pancuronium administration. Reversal of neuromuscular blockade was complete and predictable in all patients; however, the shortest duration of anesthesia in this study was 55 minutes. It is concluded that pancuronium bromide (0.1 mg./kg.) should provide a valuable alternative to d-tubocurarine for intubation and subsequent relaxation in adults from 18 to 86 years of age. Findings were consonant with the hypothesis that a depolarizing muscle relaxant need not be used with pancuroninum.
Key concepts: Medicine, Pancuronium bromide, Muscle relaxant, Anesthesia, Fentanyl, Muscle relaxation, Intubation, Vecuronium bromide